Vaxxinity Reports First Quarter 2023 Financial Results and

CAPE CANAVERAL, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of...

Related Keywords

United States ,Washington ,Boston ,Massachusetts ,Australia ,United Kingdom ,American ,Jon Yu ,Alexander Rumyantsev ,Mark Joinnides ,Sarah Despres ,Vaxxinity Inc ,World Vaccine Congress ,American Academy Of Neurology Annual Meeting ,Frontier Exploration Laboratory ,Nasdaq ,Exchange Commission On ,Chief Executive Officer ,Cape Canaveral ,Senior Vice President ,American Academy ,Neurology Annual Meeting ,Lessons Learned ,Way Forward ,Fireside Chat ,Therapeutic Area Head ,Infectious Diseases ,Private Securities Litigation Reform Act ,Annual Report ,Exchange Commission ,Nasdaq Vaxx ,Vaxxinity ,Nc ,